Back

Hemoglobin and long-term risk of death in patients with acute myocardial infarction

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (3) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marija Todorovic Markovic

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Association of free fatty acids with long-term adverse outcomes in patients with premature myocardial infarction: a prospective cohort study
Professor J. Gao (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Plasma proteomics based sub-phenotypes in coronary artery disease are related to plaque characteristics and clinical outcome
Doctor J. Veiga-Fernandes Mira (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Comparison of generation 6 and generation 5 high-sensitivity cardiac troponin T assays in the early diagnosis of myocardial infarction
Doctor L. Koechlin (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of clonal haematopoiesis of indeterminate potential-mutations with inflammation biomarkers in patients with STEMI
Doctor X. Zhao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
What is the optimal single sample rule out threshold using a point of care high-sensitivity troponin i assay?
Doctor J. Hatherley (Liverpool, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials
thumbnail
Congress Session
Improving prognostication in chronic coronary syndromes
thumbnail
Congress Presentation
Association between in-hospital haemoglobin drop with or without overt bleeding and long-term clinical outcomes after percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources